EUVIMEDEUVIMED entdecken
Crossref

High-safety tacrolimus nanoemulsion for dry eye disease treatment through anti-oxidant and anti-inflammatory effects

Meixing Shi, Xuemeng Guo, Kedong Sun, Litong Wang, Yanyan Zhou, Huiqi Wang, Weigen Qiu, Yingying Shi, Zeliang Lou, Yuena Zhang, Lihua Luo, Jian You

Nanoscale · 2026

DOI: 10.1039/d5nr03630e ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nanoscale, 2026. Verfasst von Meixing Shi und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou, Zhejiang 310058, P. R. China. shimeixing@zju.edu.cn. Hauptthemen laut MEDLINE: Tacrolimus, Antioxidants, Dry Eye Syndromes, Anti-Inflammatory Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Schematic comparison of FK@NE and Talymus for the treatment of dry eye disease. The graphic was created in https://BioRender.com and Adobe Illustrator.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TacrolimusAntioxidantsDry Eye SyndromesAnti-Inflammatory AgentsNanoparticlesEmulsionsHumansAnimalsVitamin EOxidative StressApoptosis

Substanzen

TacrolimusAntioxidantsEmulsionsAnti-Inflammatory AgentsVitamin E

Autor:innen und Institutionen

  • College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou, Zhejiang 310058, P. R. China. shimeixing@zju.edu.cn.
  • College of Pharmaceutical Science & Collaborative Innovation Centre of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, P. R. China. 221123230075@zjut.edu.cn.
  • Jinhua Institute of Zhejiang University, Jinyi New District, Jinhua, Zhejiang 321015, P. R. China.
  • State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, 79 Qingchun Road, Shangcheng District, Hangzhou, Zhejiang 310006, P. R. China.
  • The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 QingChun Road, Hangzhou, Zhejiang 310000, P. R. China.

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation

Zitieren

APA

Shi, M., Guo, X., Sun, K., Wang, L., Zhou, Y., Wang, H., Qiu, W., Shi, Y., Lou, Z., Zhang, Y., Luo, L., & You, J. (2026). High-safety tacrolimus nanoemulsion for dry eye disease treatment through anti-oxidant and anti-inflammatory effects. Nanoscale. https://doi.org/10.1039/d5nr03630e

Vancouver

Shi M, Guo X, Sun K, Wang L, Zhou Y, Wang H, et al. High-safety tacrolimus nanoemulsion for dry eye disease treatment through anti-oxidant and anti-inflammatory effects. Nanoscale. 2026. doi:10.1039/d5nr03630e

BibTeX
@article{Shi2026,
  author = {Shi, Meixing and Guo, Xuemeng and Sun, Kedong and Wang, Litong and Zhou, Yanyan and Wang, Huiqi and Qiu, Weigen and Shi, Yingying and Lou, Zeliang and Zhang, Yuena and Luo, Lihua and You, Jian},
  title = {High-safety tacrolimus nanoemulsion for dry eye disease treatment through anti-oxidant and anti-inflammatory effects},
  journal = {Nanoscale},
  year = {2026},
  doi = {10.1039/d5nr03630e}
}
Kostenlos starten →